The well-known oncogenic functions of high-risk HPV include the deregulated expression of viral oncogenes E6 and E7, which inactivate the master tumor suppressors, p53 and Rb proteins, respectively, by accelerating proteolytic degradation [3]. This evidence concerns the gene TP53 and neoplasm.